The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Mining gains offset by falls from airline, healthcare stocks

Tue, 07th Oct 2014 11:36

Poor economic data was weighing on UK stocks on Tuesday, with decent gains in the mining sector offset by falls from airlines and pharmaceuticals.The FTSE 100 was trading 0.6% lower at 6,522 by around midday.Nervousness ahead of the start of third-quarter earnings season in the States was also causing investors to tread cautiously, with US stock futures trading firmly lower ahead of the opening bell.German, UK industrial productionEconomic news wasn't helping sentiment in early deals after it was revealed that German industrial production dropped by 4% in August, pulling back after a revised 1.6% increase in July. The consensus estimate was for a lesser decline of 1.5%.The figures followed further weak figures from Germany on Monday which showed that factory orders in August slumped 5.7% after 4.9% growth in July. This was the biggest slump since 2009.Closer to home, UK industrial production was flat in August after a 0.4% expansion in July, though this was in line with estimates.Analysts at Capital Economics said that the industrial recovery in Britain is "still lacking momentum" and the data showed that the economic recovery "remained unbalanced in the third quarter".Rio Tinto jumps after Glencore approach revealedRio Tinto rose strongly after confirming that Glencore had approached the company in July about a "possible combination", though the board had rejected the approach as it "was not in the best interests of [...] shareholders".Rio Tinto was responding to press speculation after Bloomberg earlier said that Glencore was in talks with Rio Tinto's biggest shareholder, Chinalco, to gauge its interest in a potential deal. These discussions had taken place in recent weeks, sources said.Others in the sector were also on the rise, including Antofagasta, Randgold Resources and Centamin. Antofagasta was given a lift by an upgrade to 'neutral' by Nomura.However, leading the downside were airlines Easyjet and IAG after a strong performance the previous session, with the latter especially hit by the news of a person contracting the Ebola virus in Spain.Pharmaceuticals were also under the weather after Morgan Stanley cut its rating on the European healthcare sector to 'underweight'. Astrazeneca, Glaxosmithkline and Shire were all lower.Tesco was continuing to recover after its recent slump after having asked another member of its senior management to step down in the wake of an investigation into accounting practices. The company was also reportedly contacted by private equity buyout company TPG about potentially acquiring Dunnhumby, the data analysis unit that runs its Clubcard loyalty scheme.Oil and gas group Cairn Energy was a high riser on the FTSE 250 after discovering oil at its FAN-1 exploration well offshore Senegal, causing shares to surge. The find "materially upgrades the prospectivity" of the Sangomar Deep Block, the company said.However, telecoms tester Spirent Communications saw shares sink after it warned that revenues and profits in the second half would be lower than previously guided due to lower demand in the US and China.Market MoverstechMARK 2,757.48 -1.27%FTSE 100 6,522.39 -0.63%FTSE 250 15,144.22 -0.87%FTSE 100 - RisersRio Tinto (RIO) 3,139.50p +4.75%Tesco (TSCO) 182.30p +3.14%Anglo American (AAL) 1,377.50p +2.19%Randgold Resources Ltd. (RRS) 4,200.00p +1.13%Standard Chartered (STAN) 1,140.50p +1.02%Admiral Group (ADM) 1,299.00p +0.70%Aberdeen Asset Management (ADN) 395.50p +0.64%Antofagasta (ANTO) 710.00p +0.50%Sports Direct International (SPD) 616.50p +0.41%Coca-Cola HBC AG (CDI) (CCH) 1,331.00p +0.30%FTSE 100 - FallersInternational Consolidated Airlines Group SA (CDI) (IAG) 349.70p -5.82%easyJet (EZJ) 1,400.00p -4.57%Carnival (CCL) 2,400.00p -3.81%Schroders (SDR) 2,287.00p -2.72%InterContinental Hotels Group (IHG) 2,271.00p -2.49%TUI Travel (TT.) 388.20p -2.29%London Stock Exchange Group (LSE) 1,821.00p -1.94%Ashtead Group (AHT) 995.00p -1.78%Petrofac Ltd. (PFC) 965.00p -1.78%Whitbread (WTB) 4,067.00p -1.76%FTSE 250 - RisersCairn Energy (CNE) 194.30p +8.00%Tullett Prebon (TLPR) 265.60p +2.55%Zoopla Property Group (WI) (ZPLA) 219.60p +1.34%Centamin (DI) (CEY) 58.60p +1.30%Lonmin (LMI) 170.00p +1.25%Countrywide (CWD) 471.60p +1.20%Merlin Entertainments (MERL) 348.70p +0.87%Kazakhmys (KAZ) 252.00p +0.72%Ted Baker (TED) 2,013.00p +0.65%Hikma Pharmaceuticals (HIK) 1,770.00p +0.51%FTSE 250 - FallersSpirent Communications (SPT) 79.70p -19.21%Just Retirement Group (JRG) 120.90p -4.28%Thomas Cook Group (TCG) 114.50p -3.78%Hunting (HTG) 846.00p -3.42%Fidessa Group (FDSA) 2,236.00p -3.20%EnQuest (ENQ) 99.85p -2.96%Enterprise Inns (ETI) 118.10p -2.88%Telecity Group (TCY) 713.50p -2.86%Spirax-Sarco Engineering (SPX) 2,759.00p -2.41%Big Yellow Group (BYG) 498.70p -2.41%
More News
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.